LinkedIn image ad examples

Fluktuation, Fehltage, geringes Engagement – psychische Belastungen kosten Unternehmen jeden Tag Geld. Durchschnittlich 33 Krankheitstage pro betroffener Person und Jahr, bei rund 250 € Kosten pro Fehltag. Mit Instahelp gibst du deinem Team Zugang zu psychologischer Online-Beratung: ✓ Über 400 Top-Psycholog:innen. ✓ Erstkontakt binnen 24 Stunden. ✓ In über 20 Sprachen verfügbar. ✓ Anonym, Ende-zu-Ende-verschlüsselt, DSGVO-konform. Über 200+ führende Unternehmen vertrauen bereits auf Instahelp – von Mercedes-Benz Consulting bis KPMG. 👉 Jetzt unverbindliches Angebot anfordern

¿Sus pacientes con insomnio crónico no siempre le cuentan lo que realmente les preocupa en consulta? Un grupo multidisciplinar de expertos ha consensuado estrategias de comunicación prácticas para reforzar la alianza terapéutica y mejorar la adherencia en el manejo del insomnio crónico. 👉 Descubra las recomendaciones del consenso de expertos.

Kein Apfel der Welt hilft, wenn Mitarbeitende nachts wach liegen, weil Deadlines, Konflikte im Team oder private Sorgen keine Ruhe lassen. Obstkorb und Co. sind nett. Aber mentale Gesundheit braucht mehr als klassische Benefits. Sie braucht echte Unterstützung. Mit Instahelp gibst du deinem Team Zugang zu psychologischer Online-Beratung: ✔️ Über 400 qualifizierte Psycholog:innen statt Chatbots ✔️ Erstkontakt zur Terminvereinbarung binnen 24 Stunden ✔️ Vertraulich, flexibel und auch außerhalb der Arbeitszeiten verfügbar ✔️ Einfach eingeführt, mit persönlicher Unterstützung für HR Weil gesunde Teams mehr brauchen als gesunde Snacks. 👉 Jetzt unverbindlich anfragen

With rapid market growth, major patent expirations and innovative therapies reshaping the competitive landscape, the race for immunology leadership is on. In the latest episode of Evaluate Spotlight, discover which companies are positioned to lead through 2032, where dealmaking is heading and how precision approaches are opening new opportunities.

AI may be everywhere in commercial pharma, but defensible answers are much harder to find. While most teams are testing general-purpose tools, these platforms often lack the curated data, pharmaceutical context and traceability needed to support decisions with real commercial consequences. Explore the infographic to see what separates AI built for demos from AI built for decisions.

Dores de cabeça, vômitos, sonolência, quedas e mudanças de comportamento podem gerar dúvidas e preocupação entre pais e responsáveis. Esses foram alguns dos pontos abordados pelo Dr. Sérgio Cavalheiro - RQE 47861, neurocirurgião pediátrico do Hospital Santa Catarina - Paulista, em entrevista à Rádio Disney Brasil. Durante a conversa, ele explicou quais sinais merecem atenção, como é feita a investigação e em quais situações uma cirurgia pode ser considerada. Assista à entrevista completa no YouTube: https://lnkd.in/dhJdyDUq #HospitalSantaCatarinaPaulista #NeurocirurgiaPediátrica #Pediatria

Does your MS assay measure these as the same protein? One shared peptide gives all three a match.

Finding the balance between taking care of patient data and moving quickly is really important. While ethical and privacy reviews are being done, cures and interventions are delayed. Worse, because there is so much anticipated waiting around, many projects never even start. Not everyone has the luxury of time. We have got to find more ways to move fast without breaking things. That is what we're doing at Subsalt. https://lnkd.in/dChYzjWn

Healthcare employees reach for shadow AI when there’s no approved option -- Subsalt gives your whole health system an approved option in less than half the time it takes to respond to a data request today. Yep, we've created the solution to committee purgatory. General-purpose AI chat tools connect to a de-identified twin of your patient data, and PHI stays inside your security boundary. So the people who run your health system can ask questions that need patient data without joining the data analyst queue or submitting a BI build request.

Your go or no-go call is only as good as your standard. Ours are matched heavy and light pairs, built for absolute quantification.

Expressing a herbicide tolerance trait is only half the battle, producing enough active protein is where pipelines stall. This latest technical article explores: 🟢 Protein supply gaps: Moving past plant extraction limits to secure regulatory test material. 🟢 Herbicide tolerance trait classes: Roles and tolerance pathways across major commercial enzymes. 🟢 Biomanufacturing hurdles: Highlighting solubility, assembly, and cofactor challenges in conventional hosts. ➡️ Explore the full article here 👇

With 12 pieces of research being presented, including two rapid oral presentations, our team is looking forward to joining the international oncology community at #ESMO26! Come learn more about Foundation Medicine and how we are helping to advance precision medicine through our high-quality tests and services. Explore our accepted research: https://lnkd.in/en5443jp/?utm_campaign=Boost_Post_WebsiteVisits_Oct21,2026&utm_source=linkedin&utm_medium=paid&utm_id=1236098816&hsa_acc=510184245&hsa_cam=1236098816&hsa_grp=917089136&hsa_ad=1655300106&hsa_net=linkedin&hsa_ver=3

Forbes named me one of its 250 Greatest Living American Optimists this week, which prompted a useful question: what, exactly, am I optimistic about? Quite a lot. I’m optimistic about science because our ability to observe the world keeps improving. We can measure phenomena that were invisible to us a generation ago, run experiments at extraordinary scale, and replace intuition with evidence more quickly and precisely than before. I’m optimistic about AI because we are still early in discovering what it can do beyond the digital world. I am most excited about bringing computation and experimentation together to understand complex systems that today are largely illegible to both human and machine intelligence. Human biology is the example I care most about. Biology continually surprises us, and the only definitive experiment is the one performed in a human being. The information we need often does not exist until we build the experiments capable of revealing it. AI is very good at connecting dots, but it cannot connect dots that have never been measured, and measuring them is a lot of work. We now have the technology to collect better measurements, generate stronger causal evidence, and build more powerful models from both. That lets us retire weak hypotheses before they reach patients and choose interventions with more confidence. Over time, it can make drug discovery more predictable. The well of human biology is very, very deep. But we do not need to reach the bottom before we start delivering value to patients. I see reasons for optimism in the work immediately ahead of us too: our first programs at insitro moving toward the clinic in MASH, ALS and dry AMD; what we will learn with our new collaborators at AstraZeneca in MASH and cardiomyopathies; and what becomes possible when people from very different fields bring different ways of seeing to the same hard problem. There is plenty in the world that warrants concern. There is also more scientific capability and computational power available to us than at any point in history. It is an honor to be on this list alongside people who have spent their careers investing time, talent and conviction in possibilities that did not yet exist. I am most optimistic about changing the outcome for the patients who are waiting for all of us to get this right. https://lnkd.in/dqZwKPJq

insitro is proud to announce that biotech companies in the Lilly TuneLab™ network can now deploy advanced machine learning models built by insitro with Eli Lilly and Company (Lilly) to predict in vitro and, critically, in vivo properties of small molecules — representing collective progress advancing the field of AI drug discovery on behalf of patients. We're discussing the news live at SF Tech Week today, where Mary Rozenman, PhD, insitro CFO and CBO, joins Aliza Apple, PhD, Vice President of Catalyze360 AI/ML and Global Head of Lilly TuneLab, at the a16z Bio + Health & Lilly TuneLab biotech breakfast. In advance of the discussion, Mary explained, “We built insitro to make biology an AI problem, with scaled data and models at the frontier. Our in-house data scaling helps us predict which biology we should target to impact disease in vivo. Today’s announcement with Lilly takes the next step. Now we’re predicting how a molecule will behave in vivo so we can make better decisions earlier in R&D by trading upfront compute for downstream conviction. We are thrilled to ship these models on TuneLab to enable this way of working across their ecosystem.” Trained on multi-species preclinical data that Lilly generated over decades of research from hundreds of thousands of unique molecules, the models offer a powerful alternative to today’s industry standard method of extrapolation from in vitro assays, providing an enterprise-grade capability traditionally available only to organizations with the scale to generate such data volumes themselves. The models will be updated as the dataset continues to expand. "The question of a molecule's in vivo behavior has been an empirical question, answered experimentally, slowly, one compound at a time. These models make it a computational question first," said Daphne Koller, PhD, founder and CEO of insitro. The in vivo PK models are a critical component of our TherML™ platform for small molecule discovery, alongside machine learning and physics-based in silico screening, affinity models powered by proprietary DNA-encoded libraries, and an active-learning medicinal chemistry engine. → Read our official announcement: https://lnkd.in/gzdTa8UF → Learn more about how the models work: https://lnkd.in/gGmVmvRi #SFTechWeek #AI #ML #LillyTuneLab #drugdiscovery

If you’re 18-25 and trying to figure out your next professional move, headspace Career Mentoring is here to bridge the gap.

Zorgvraag of calamiteit? Jij houdt de koers vast in complexe situaties. Word ANW-coördinator in Noordwijk en Zuid-Holland.

Ben jij de collega die we kunnen bellen als het spannend wordt? Maak het verschil bij 's Heeren Loo in Noordwijk en Zuid-Holland.

Mobile Cleaning Inspection App. No paper, no data re-entry. Select rooms to inspect by assignment, floor, department, and more. Monitor each cleaning step — get a clear picture of successes and places where your team requires more training. View results immediately with built-in or custom charts. See how it works. https://lnkd.in/ea4zW29s

In obesity trials, enrollment is only half the job. Long treatment periods test patient retention strategies. Flourish Research brings proven recruitment and retention, plus experienced cardiometabolic PIs, across a wholly-owned U.S. site network.

Planning significant benefits changes for 2027? New plans, vendors, and programs can create more choice, but they can also create confusion. When employees don't know where to turn, what's covered, or how to make informed healthcare decisions, even the best benefits strategy can fall short. Health Advocate helps create one connected experience that simplifies navigation, delivers personalized support, and helps employees get the most from their benefits. Learn how we can help make change easier: https://lnkd.in/eKtA7a7n

There's a meaningful story behind the new welcome sign at CONNECT Saanich Peninsula. 💙 Learn more about the carving, its symbolism, and the community celebration in our latest blog. 🔗 https://lnkd.in/g35rZTwb #CONNECTCommunities #CONNECTSaanich #Community #IndigenousArt #WSANEC

We’re in Madrid for ESMO 2026. Stop by our booth to speak to our oncology leaders about how we're transforming complex scientific insights into therapies for patients worldwide.

Innovation moves quickly in today’s nutraceutical market. Your next launch should too. Meet the Catalent team at SupplySide Global to explore ready-to-market formulations and consumer-preferred delivery formats designed for fast-growing categories, including sports nutrition, women’s health and metabolic support Visit us at Booth #4273 to discover how the Catalent Portfolio Accelerator™ can help turn your next idea into a market-ready solution, faster. Book a meeting with the team here: https://lnkd.in/di43K2A4 #SupplySideGlobal #Nutraceuticals #ProductDevelopment #Catalent

Arbejder du med slidte og eroderede tandsæt? Så er F.I.T. måske relevant for dig. På vores hands-on-kursus i Aarhus lærer du Forma Injektion Teknik at kende fra A til Z. Du får indblik i planlægning, digitale og analoge arbejdsgange samt samarbejdet med laboratoriet. Du får samtidig mulighed for selv at afprøve teknikken gennem praktiske øvelser. ⏳ Kurset afholdes allerede den 28. oktober – så det er ved at være sidste chance for at tilmelde sig! 👉 Læs mere og tilmeld dig: